Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 2/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | JAK2 | O60674 | 1/20 | 0.31 |
| ▸ | JAK1 | P23458 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6174189 | 0.89 | IGF1R (0.42) | IGF1RJAK2JAK1LMNATRPV3 | |
| SCHEMBL6250336 | 0.83 | IGF1R (0.43) | IGF1RCNR1JAK2JAK1LMNA | |
| SCHEMBL6173787 | 0.81 | IGF1R (0.42) | IGF1RLMNA | |
| SCHEMBL6173280 | 0.81 | IGF1R (0.42) | IGF1RCNR1JAK2JAK1LMNA | |
| SCHEMBL6172371 | 0.79 | IGF1R (0.45) | IGF1RLMNATRPV3 | |
| SCHEMBL6175238 | 0.79 | IGF1R (0.43) | IGF1RLMNATRPV3 | |
| SCHEMBL6174902 | 0.79 | SMN1; SMN2 (0.39) | IGF1RLMNA | |
| SCHEMBL6172919 | 0.78 | IGF1R (0.43) | IGF1RLMNATRPV3 | |
| SCHEMBL6173570 | 0.78 | IGF1R (0.43) | IGF1RLMNATRPV3 | |
| SCHEMBL6173471 | 0.78 | IGF1R (0.42) | IGF1RLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599464-A2 | NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | Aventis Pharma S.A. (FR) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004070050-A2 | CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | AVENTIS PHARMA S.A. (FR) | 2004-08-19 | — | — | WO | disclosed |